Rig-I regulates NF-κB activity through binding to Nf-κb1 3′-UTR mRNA

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 16, 2013, Pages 6459-6464

  Zhang, Hong Xin ^a,b   Liu, Zi Xing ^b   Sun, Yue Ping ^b   Zhu, Jiang ^a   Lu, Shun Yuan ^a,c   Liu, Xue Song ^b   Huang, Qiu Hua ^a   Xie, Yin Yin ^a   Zhu, Hou Bao ^b   Dang, Su Ying ^b   Chen, Hai Feng ^d,e   Zheng, Guang Yong ^d   Li, Yi Xue ^d   Kuang, Ying ^c   Fei, Jian ^c   Chen, Sai Juan ^a   Chen, Zhu ^a   Wang, Zhu Gang ^a,b,c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Research Center for Model Organisms   (China)

^d SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MESSENGER RNA; NUCLEAR FACTOR KAPPA B1; RETINOIC ACID INDUCIBLE PROTEIN I; RIBOSOMAL PROTEIN L13; RIBOSOMAL PROTEIN L8; RIBOSOME PROTEIN; RIBOSOME RNA; UNCLASSIFIED DRUG; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RNA TRANSLATION; SIGNAL TRANSDUCTION; TANDEM REPEAT; VIRUS IMMUNITY;

3' UNTRANSLATED REGIONS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DEAD-BOX RNA HELICASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; LUCIFERASES; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS SIMULATION; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84876272628     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304432110     Document Type: Article

References (39)

1. Yoneyama M, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730-737.
2. Kawai T, et al. (2005) IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6(10):981-988.
3. Meylan E, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437(7062):1167-1172.
4. Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122(5):669-682.
5. Xu LG, et al. (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19(6):727-740.
6. Hornung V, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314(5801):994-997.
7. Pichlmair A, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314(5801):997-1001.
8. Schlee M, et al. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31(1):25-34.
9. Schmidt A, et al. (2009) 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA 106(29):12067-12072.
10. Habjan M, et al. (2008) Processing of genome 5′ termini as a strategy of negativestrand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 3(4): e2032.
11. Wang Y, et al. (2010) Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 17(7):781-787.
12. Lu C, et al. (2010) The structural basis of 5′ triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 18(8):1032-1043.
13. Hwang SY, et al. (2012) 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity. Nucleic Acids Res 40(6):2724-2733.
14. Civril F, et al. (2011) The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Rep 12(11):1127-1134.
15. Jiang F, et al. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479(7373):423-427.
16. Kowalinski E, et al. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147(2):423-435.
17. Luo D, et al. (2011) Structural insights into RNA recognition by RIG-I. Cell 147(2):409-422.
18. Liu TX, et al. (2000) Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 96(4):1496-1504.
19. Takahasi K, et al. (2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29(4):428-440.
20. de la Cruz J, Kressler D, Linder P (1999) Unwinding RNA in Saccharomyces cer-evisiae: DEAD-box proteins and related families. Trends Biochem Sci 24(5):192-198.
21. Rocak S, Emery B, Tanner NK, Linder P (2005) Characterization of the ATPase and unwinding activities of the yeast DEAD-box protein Has1p and the analysis of the roles of the conserved motifs. Nucleic Acids Res 33(3):999-1009.
22. Liu F, Gu J (2011) Retinoic acid inducible gene-I, more than a virus sensor. Protein Cell 2(5):351-357.
23. -/- mice develop colitis associated with downregulation of G alpha i2. Cell Res 17(10):858-868.
24. Zhang NN, et al. (2008) RIG-I plays a critical role in negatively regulating granulocytic proliferation. Proc Natl Acad Sci USA 105(30):10553-10558.
25. Jiang LJ, et al. (2011) RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc Natl Acad Sci USA 108(5):1897-1902.
26. Kong L, et al. (2009) An essential role for RIG-I in toll-like receptor-stimulated phagocytosis. Cell Host Microbe 6(2):150-161.
27. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405-455.
28. May MJ, Ghosh S (1997) Rel/NF-kappa B and I kappa B proteins: An overview. Semin Cancer Biol 8(2):63-73.
29. Glisovic T, Bachorik JL, Yong J, Dreyfuss G (2008) RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 582(14):1977-1986.
30. Sharma S, Ding F, Dokholyan NV (2008) iFoldRNA: Three-dimensional RNA structure prediction and folding. Bioinformatics 24(17):1951-1952.
31. Duan Y, et al. (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24(16):1999-2012.
32. Kollman PA, et al. (1997) The Development/Application of a 'Minimalist' Organic/Biochemical Molecular Mechanic Force Field using a Combination of ab Initio Calculations and Experimental Data. In Computer Simulation of Biomolecular Systems, eds. van Gunsteren WF, Weiner PK, Wilkinson AJ (Kluwer Academic Publishers, Dordrecht, the Netherlands), pp 83-96.
33. Gal-Ben-Ari S, et al. (2012) Consolidation and translation regulation. Learn Mem 19 (9):410-422.
34. Kuersten S, Goodwin EB (2003) The power of the 3' UTR: Translational control and development. Nat Rev Genet 4(8):626-637.
35. Mazumder B, Seshadri V, Fox PL (2003) Translational control by the 3'-UTR: The ends specify the means. Trends Biochem Sci 28(2):91-98.
36. Wilkie GS, Dickson KS, Gray NK (2003) Regulation of mRNA translation by 5'-and 3-UTR-binding factors. Trends Biochem Sci 28(4):182-188.
37. Mazumder B, Seshadri V, Imataka H, Sonenberg N, Fox PL (2001) Translational silencing of ceruloplasmin requires the essential elements of mRNA circularization: Poly(A) tail, poly(A)-binding protein, and eukaryotic translation initiation factor 4G. Mol Cell Biol 21(19):6440-6449.
38. Chen FW, Ioannou YA (1999) Ribosomal proteins in cell proliferation and apoptosis. Int Rev Immunol 18(5-6):429-448.
39. Unbehaun A, et al. (2007) Position of eukaryotic initiation factor eIF5B on the 80S ribosome mapped by directed hydroxyl radical probing. EMBO J 26(13): 3109-3123.